Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

3:25 PM - 3:30 PM ET

1046 - Hematologic Toxicity, Treatment Completion Time, and Dosimetric Comparison between Proton and Photon Craniospinal Irradiation in Pediatric Tumor Patients: A Propensity Score-Matched Study
Speaker: Li, Ran, PhD - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong
3:25 PM - 3:30 PM ET

1053 - Phase II Study of Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost (SBRT-SIB) Delivered on an MR-LINAC for Intermediate and High Risk Prostate Cancer: 2 Year Outcomes
Speaker: Weg, Emily, MD - Weill Cornell Medicine, New York, NY
3:25 PM - 3:30 PM ET

1064 - Assessment of Image Guidance and Adaptive Planning on the ART of SABR Phase II Trial for Near "Margin-Less" Adaptive Radiation Therapy of Primary Localized Prostate Cancer
Speaker: Morris, Toby, PhD - Mayo Clinic Rochester, Rochester, MN
3:25 PM - 3:30 PM ET

1076 - Spatiotemporal AI Morphometry for Early Recurrence Assessment in Rectal Cancer After Neoadjuvant Chemoradiotherapy: A Multi-Model Ablation Study
Speaker: Chen, Shenlun, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
3:25 PM - 3:30 PM ET

1286 - Comparative Evaluation of Immune, Hypoxia, and DNA Repair Transcriptomic Signatures for Predicting Radiation Therapy Response in Head and Neck Squamous Cell Carcinoma
Speaker: Lasington, Jeril, MD, MS, MBBS - New York Medical College at St.Mary's and St. Clare's, Denville, NJ
3:30 PM - 3:35 PM ET

1047 - Predicting Survival and Treatment Completion of Proton Craniospinal Irradiation in Leptomeningeal Disease: A Prognostic Nomogram
Speaker: Kanala, Tejaswi, MD, MBBS - Yashoda Cancer Institute, Hyderabad, Somerset, NJ
3:30 PM - 3:35 PM ET

1077 - Dynamic Delta-Radiomics and Clinical Fusion Model for Predicting Disease-Free Survival In Locally Advanced Cervical Cancer: A Multi-Cohort Study
Speaker: Wang, Weiping, MD, PhD - Peking Union Medical College Hospital, Beijing, Beijing
3:30 PM - 3:40 PM ET

213 - Circulating Tumor DNA (ctDNA) as an Early Predictive Biomarker of Response In Locally Advanced Cervical Cancer Treated with the Interlace Regimen: A Preliminary Report
Speaker: Gui, Bin, MD, MS - UNC Health, Chapel Hill, NC
3:30 PM - 3:40 PM ET

218 - CDCP1-Directed 89 Zr/ 177 Lu Radiotheranostics for Radioresistant Non-Small Cell Lung Cancer
Speaker: Liu, Jie, MD, PhD - Shandong Cancer Hospital and Institute, Jinan, Shandong
3:30 PM - 3:40 PM ET

224 - Event-Free Survival after Definitive Radiotherapy vs. Upfront Surgery for Axillary and Inguinal Nodal Merkel Cell Carcinoma: A Population-Based Retrospective Analysis
Speaker: Stoker, Daniel, MD - Princess Alexandra Hospital, Woolloongabba, QLD
3:30 PM - 3:35 PM ET

3258 - Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) for Pelvic Reirradiation: A Phase 1/2 Trial
Speaker: Droznin, Alexander - Brigham and Women's Hospital / Dana-Farber Cancer Institute, Boston, MA
3:30 PM - 3:50 PM ET

Questions & Answers
Speaker: Shen, Colette, MD, PhD - University of North Carolina School of Medicine & Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina